Litcius/Paper detail

Human Serum Albumin-Oxaliplatin (Pt(IV)) prodrug nanoparticles with dual reduction sensitivity as effective nanomedicine for triple-negative breast cancer

Milan Paul, Balaram Ghosh, Swati Biswas

2023International Journal of Biological Macromolecules21 citationsDOI

Topics & Concepts

OxaliplatinNanomedicineCytotoxicityProdrugHuman serum albuminChemistryDrug deliveryDrugPharmacologyTriple-negative breast cancerTargeted drug deliveryCancer researchCancerBreast cancerMaterials scienceNanoparticleMedicineIn vitroNanotechnologyBiochemistryInternal medicineColorectal cancerOrganic chemistryNanoparticle-Based Drug DeliveryNanocluster Synthesis and ApplicationsMetal complexes synthesis and properties
Human Serum Albumin-Oxaliplatin (Pt(IV)) prodrug nanoparticles with dual reduction sensitivity as effective nanomedicine for triple-negative breast cancer | Litcius